Sukla Sunil Kumar, Mohanty Pradeep Kumar, Patel Siris, Das Kishalaya, Hiregoudar Mrutyunjay, Soren Uttam Kumar, Meher Satyabrata
Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Burla, Sambalpur, Odisha, India.
Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Burla, Sambalpur, Odisha, India; Odisha Sickle Cell Project (NHM), Sickle Cell Institute, VIMSAR, Burla, Sambalpur, Odisha, India.
Hematol Transfus Cell Ther. 2023 Jul;45 Suppl 2(Suppl 2):S11-S17. doi: 10.1016/j.htct.2021.06.012. Epub 2021 Sep 11.
During pregnancy, the iron requirement increases to meet the optimal growth of the fetus and prevent iron deficiency anemia-related complications in the mother. However, in sickle cell disease (SCD) primarily due to repeated blood transfusions and hemolysis-induced recycling of iron, its supplementation during pregnancy remains questionable and may be harmful.
Twenty-five pregnant women with homozygous SCD and 25 pregnant women with normal hemoglobin variants were included as cases and control, respectively. Pregnancy and sickle cell anemia (SCA) were diagnosed using standard protocols. The serum iron, serum ferritin, total iron-binding capacity (TIBC), percentage transferrin saturation and C-reactive protein were estimated, as per the manufacturer's protocol. The complete blood count was performed. The unpaired 't-test' was performed using the SPSS v23.0 and the principal component analysis (PCA) was performed using the online software MetaboAnalyst for statistical analysis.
The studied cases had significantly lower mean hemoglobin and higher mean corpuscular volume (MCV), compared to controls. The mean serum-iron, serum-ferritin and percentage transferrin-saturation in the cases were significantly higher than that of the controls, while the TIBC was lower in the cases (p < 0.0001). The mean level of serum iron, ferritin, percentage transferrin saturation and TIBC were 309.44 ± 122.40mcg/dl, 860.36 ± 624.64ng/ml, 42.6 ± 17.30% and 241.32 ± 96.30 mcg/dl, respectively, in the cases and 95.36 ± 41.90mcg/dl, 122.28 ± 49.70ng/ml, 15.83 ± 3.10% and 492.6 ± 149.40mcg/dl in the controls, respectively. Higher MCV, mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC) with lower hemoglobin (Hb) were noted in the cases. The PCA revealed that the cases were more heterogeneous in terms of the variability of the iron status and hematological indices than the controls.
The current study shows iron sufficiency in most cases of pregnancy with SCA and suggests that evaluation of iron status must be made before initiating iron prophylaxis in pregnant women with SCA, especially in regions having a high prevalence of sickle cell hemoglobinopathy.
孕期铁需求量增加,以满足胎儿的最佳生长需求并预防母亲发生缺铁性贫血相关并发症。然而,在镰状细胞病(SCD)中,主要由于反复输血和溶血导致铁的再循环,孕期补充铁剂仍存在疑问且可能有害。
分别纳入25例纯合子SCD孕妇和25例血红蛋白正常变异型孕妇作为病例组和对照组。采用标准方案诊断妊娠和镰状细胞贫血(SCA)。按照制造商的方案测定血清铁、血清铁蛋白、总铁结合力(TIBC)、转铁蛋白饱和度百分比和C反应蛋白。进行全血细胞计数。使用SPSS v23.0进行非配对“t检验”,并使用在线软件MetaboAnalyst进行主成分分析(PCA)以进行统计分析。
与对照组相比,研究病例组的平均血红蛋白显著降低,平均红细胞体积(MCV)更高。病例组的平均血清铁、血清铁蛋白和转铁蛋白饱和度百分比显著高于对照组,而病例组的TIBC较低(p < 0.0001)。病例组血清铁、铁蛋白、转铁蛋白饱和度百分比和TIBC的平均水平分别为309.44 ± 122.40mcg/dl、860.36 ± 624.64ng/ml、42.6 ± 17.30%和241.32 ± 96.30 mcg/dl,对照组分别为95.36 ± 41.90mcg/dl、122.28 ± 49.70ng/ml、15.83 ± 3.10%和492.6 ± 149.40mcg/dl。病例组中观察到MCV、平均红细胞血红蛋白(MCH)和平均红细胞血红蛋白浓度(MCHC)较高而血红蛋白(Hb)较低。PCA显示,与对照组相比,病例组在铁状态和血液学指标的变异性方面更加异质。
当前研究表明,大多数SCA孕妇病例中铁充足,并建议在对SCA孕妇开始铁预防之前,尤其是在镰状细胞血红蛋白病高发地区,必须对铁状态进行评估。